Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orion OYJ Total Liabilities and Share Holders Equity 2017-2024 | ORINY

Orion OYJ total liabilities and share holders equity from 2017 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • Orion OYJ total liabilities and share holders equity for the quarter ending June 30, 2024 was $1.569B, a 10.04% increase year-over-year.
  • Orion OYJ total liabilities and share holders equity for 2023 was $1.557B, a 1.72% decline from 2022.
  • Orion OYJ total liabilities and share holders equity for 2022 was $1.584B, a 20.2% increase from 2021.
  • Orion OYJ total liabilities and share holders equity for 2021 was $1.318B, a 3.42% increase from 2020.
  
Orion OYJ Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $1,557
2022 $1,584
2021 $1,318
2020 $1,274
2019 $1,160
2018 $1,354
2017 $1,193
2016 $1,176
Orion OYJ Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $1,569
2024-03-31 $1,586
2023-12-31 $1,557
2023-09-30 $1,493
2023-06-30 $1,426
2023-03-31 $1,387
2022-12-31 $1,584
2022-09-30 $1,579
2022-06-30 $1,352
2022-03-31 $1,374
2021-12-31 $1,318
2021-09-30 $1,245
2021-06-30 $1,255
2021-03-31 $1,429
2020-12-31 $1,274
2020-09-30 $1,286
2020-06-30 $1,218
2020-03-31 $1,372
2019-12-31 $1,160
2019-09-30 $1,037
2019-06-30 $1,010
2019-03-31 $1,363
2018-12-31 $1,354
2018-09-30 $1,266
2018-06-30 $1,280
2018-03-31 $1,249
2017-12-31 $1,193
2017-09-30 $1,140
2017-06-30 $1,042
2017-03-31 $999
2016-12-31 $1,176
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.653B $1.288B
Orion Oyj is a pharmaceutical company. It develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company's core therapy consists of central nervous system disorders, oncology and respiratory. Its product pipeline includes inhaled Easyhaler(R) pulmonary drugs. Orion Oyj is headquartered in Espoo, Finland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.725B 30.68
Takeda Pharmaceutical (TAK) Japan $42.414B 8.83
Sandoz Group AG (SDZNY) Switzerland $19.283B 0.00
Merck (MKKGY) Germany $18.792B 16.83
Astellas Pharma (ALPMY) Japan $18.332B 16.88
United Therapeutics (UTHR) United States $16.401B 16.13
Summit Therapeutics (SMMT) United States $13.584B 0.00
Neurocrine Biosciences (NBIX) United States $12.656B 33.51
Shionogi (SGIOY) Japan $11.814B 11.32
Catalent (CTLT) United States $10.829B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.563B 7.40
Madrigal Pharmaceuticals (MDGL) United States $7.181B 0.00
Corcept Therapeutics (CORT) United States $5.859B 44.38
Ionis Pharmaceuticals (IONS) United States $5.359B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.289B 0.00
PTC Therapeutics (PTCT) United States $3.308B 0.00
Dyne Therapeutics (DYN) United States $3.026B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.578B 15.41
Catalyst Pharmaceuticals (CPRX) United States $2.519B 11.42
Soleno Therapeutics (SLNO) United States $2.356B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.272B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.061B 0.00
Evotec AG (EVO) Germany $1.896B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.859B 0.00
Xencor (XNCR) United States $1.687B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.648B 0.00
Harrow (HROW) United States $1.563B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.551B 0.00
Cassava Sciences (SAVA) United States $1.548B 0.00
Indivior (INDV) United States $1.484B 6.04
Guardian Pharmacy Services (GRDN) United States $1.397B 0.00
Ocular Therapeutix (OCUL) United States $1.339B 0.00
ARS Pharmaceuticals (SPRY) United States $1.300B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.256B 0.00
Enliven Therapeutics (ELVN) United States $1.242B 0.00
Ardelyx (ARDX) United States $1.213B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.124B 0.00
Collegium Pharmaceutical (COLL) United States $0.981B 5.35
Bioventus (BVS) United States $0.934B 29.51
Cronos Group (CRON) Canada $0.784B 0.00
Relay Therapeutics (RLAY) United States $0.777B 0.00
USANA Health Sciences (USNA) United States $0.750B 13.91
Oruka Therapeutics (ORKA) United States $0.717B 0.00
Elite Pharmaceuticals (ELTP) United States $0.660B 0.00
Exscientia (EXAI) United Kingdom $0.633B 0.00
Altimmune (ALT) United States $0.598B 0.00
Tourmaline Bio (TRML) United States $0.583B 0.00
Savara (SVRA) United States $0.556B 0.00
OmniAb (OABI) United States $0.544B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.534B 0.00
Organogenesis (ORGO) United States $0.533B 0.00
ProKidney (PROK) United States $0.507B 0.00
Zevra Therapeutics (ZVRA) United States $0.487B 0.00
Esperion Therapeutics (ESPR) United States $0.487B 0.00
Korro Bio (KRRO) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.473B 0.00
Xeris Biopharma Holdings (XERS) United States $0.453B 0.00
Siga Technologies (SIGA) United States $0.448B 5.22
Rigel Pharmaceuticals (RIGL) United States $0.441B 178.86
Aquestive Therapeutics (AQST) United States $0.411B 0.00
KalVista Pharmaceuticals (KALV) United States $0.403B 0.00
Akebia Therapeutics (AKBA) United States $0.397B 0.00
Larimar Therapeutics (LRMR) United States $0.391B 0.00
Verve Therapeutics (VERV) United States $0.389B 0.00
4D Molecular Therapeutics (FDMT) United States $0.369B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.356B 0.00
Avita Medical (RCEL) United States $0.337B 0.00
Aclaris Therapeutics (ACRS) United States $0.309B 0.00
Sage Therapeutics (SAGE) United States $0.297B 0.00
Nature's Sunshine Products (NATR) United States $0.289B 17.21
Aldeyra Therapeutics (ALDX) United States $0.286B 0.00
Lyell Immunopharma (LYEL) United States $0.256B 0.00
Silence Therapeutics (SLN) United Kingdom $0.230B 0.00
Lexeo Therapeutics (LXEO) United States $0.205B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.204B 0.00
Acrivon Therapeutics (ACRV) United States $0.201B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.197B 0.00
Nektar Therapeutics (NKTR) United States $0.186B 0.00
Profound Medical (PROF) Canada $0.185B 0.00
MediWound (MDWD) Israel $0.181B 0.00
Nanobiotix S.A (NBTX) France $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.171B 0.00
Heron Therapeutics (HRTX) United States $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.144B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.135B 0.00
Telomir Pharmaceuticals (TELO) United States $0.132B 0.00
Cardiol Therapeutics (CRDL) Canada $0.129B 0.00
Pyxis Oncology (PYXS) United States $0.125B 0.00
Context Therapeutics (CNTX) United States $0.113B 0.00
Journey Medical (DERM) United States $0.109B 0.00
Century Therapeutics (IPSC) United States $0.105B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Avalo Therapeutics (AVTX) United States $0.100B 0.00
Fractyl Health (GUTS) United States $0.099B 0.00
Karyopharm Therapeutics (KPTI) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.092B 24.14
Regulus Therapeutics (RGLS) United States $0.092B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Inotiv (NOTV) United States $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Relmada Therapeutics (RLMD) United States $0.083B 0.00
CASI Pharmaceuticals (CASI) China $0.081B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
AlloVir (ALVR) United States $0.066B 0.00
ElectroCore (ECOR) United States $0.065B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Champions Oncology (CSBR) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
BioVie (BIVI) United States $0.055B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Rafael Holdings (RFL) United States $0.050B 0.00
Iterum Therapeutics (ITRM) Ireland $0.049B 0.00
Protara Therapeutics (TARA) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
Gain Therapeutics (GANX) United States $0.043B 0.00
VYNE Therapeutics (VYNE) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.038B 0.00
CERo Therapeutics Holdings (CERO) United States $0.037B 0.00
Carisma Therapeutics (CARM) United States $0.035B 0.00
Incannex Healthcare (IXHL) Australia $0.035B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.030B 0.00
DURECT (DRRX) United States $0.027B 0.00
Lipocine (LPCN) United States $0.027B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
BioLineRx (BLRX) Israel $0.026B 0.00
GlycoMimetics (GLYC) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Enlivex Therapeutics (ENLV) Israel $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.015B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Aptorum Group (APM) United Kingdom $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.13
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 38.47